Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2031studies shown
Showing 85-96 of 2,031
Drug study icon
RecruitingNCT05017311

Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)

This study is comparing Escitalopram with placebo for people with depression. Participants receive Escitalopram or placebo and complete study visits and assessments.

Multiple locations, including Calgary
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Depression
Device study icon
RecruitingNCT04556890

Pain and Major Depressive Disorder

This study is looking at examine the effects of brain stimulation on pain symptoms associated with Major depressive disorder for people with depression or Chronic Pain. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Los Angeles
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 75 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Depression
Behavioral study icon
RecruitingNCT06740331

Social Cognition, Memory, and Executive Functions in Bipolarity and Major Depressive Disorder

This study is looking at care and outcomes for people with bipolarity and depression. Some participants may receive Bipolar controls instead of the study treatment, and direct benefit is not guaranteed.

In Reims
Why is this study shown?

This study is directly about Depression.

Depression, BipolarityBehavioralFrom 18 Years to 65 Years
Countries
France
Sponsor
CHU de Reims
Condition
Depression, Bipolarity
Drug study icon
RecruitingNCT06633016

ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

This observational study is following people with depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Autobahn Therapeutics, Inc.
Condition
Depression
Drug study icon
RecruitingNCT05850689

Lumateperone as Adjunctive Therapy in the Treatment of people with Major Depressive Disorder

This study is comparing Lumateperone with placebo for people with depression. Participants receive Lumateperone or placebo and complete study visits and assessments.

Multiple locations, including Huntsville
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Depression
Drug study icon
RecruitingNCT04480918

University of Iowa Interventional Psychiatry Service Patient Registry

This study is looking at examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and OCD (OCD) for people with depression or bipolarity. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Iowa City
Why is this study shown?

This study is directly about Depression.

Depression, Bipolarity, ...DrugFrom 18 Years to 99 Years
Countries
United States
Sponsor
Mark Niciu
Condition
Depression, Bipolarity, ...
Other study type icon
RecruitingNCT06780917

Validating the On-line Creyos Cognitive Assessment Platform in Older Adults With Major Depressive Disorder or Mild Cognitive Impairment

This study is looking at validate the Creyos online cognitive assessment platform in individuals with mild cognitive impairment, or remitted major depressive disorder for people with Mild Cognitive Impairment, depression, Remitted, or Healthy Controls Group - Age and Sex-matched. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Toronto
Why is this study shown?

This study is directly about Depression.

DepressionOtherOver 60 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Depression
Drug study icon
RecruitingNCT06547489

Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

This study is comparing Zelquistinel with placebo for people with depression. Participants receive Zelquistinel or placebo and complete study visits and assessments.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Syndeio Biosciences, Inc
Condition
Depression
Drug study icon
RecruitingNCT06668571

Intravenous Ketamine for Treatment-Resistant Depression

This study is looking at care and outcomes for people with depression, Treatment-Resistant or Treatment Resistant Depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In Rochester
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Depression
Behavioral study icon
RecruitingNCT07512284

Mindfulness Engaged Neurostimulation for Depression (MEND II)

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In San Diego
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.